September 14, 2019 /Sports News – Local US places 7th at World Cup, tops Poland 87-74 in finale; Mitchell scores 16 Associated Press Written by Tags: Donovan Mitchell/Poland/Team USA FacebookTwitterLinkedInEmailBEIJING (AP) — Donovan Mitchell scored 16 points and handed out 10 assists, Joe Harris scored 14 and the U.S. defeated Poland 87-74 on Saturday for seventh place at the World Cup.Khris Middleton had 13 points, six rebounds and six assists for the Americans, who will head home with a 6-2 record — yet their worst placing ever in a World Cup, world championship as it used to be known, or Olympics.Derrick White scored 12 and Harrison Barnes added 10 for the U.S.Mateusz Ponitka scored 18 points, Adam Waczynski had 17 and A.J. Slaughter finished with 15 for Poland (4-4), which was in the World Cup for the first time since 1967.The Americans put together a 10-0 run in the first quarter to take a 28-14 lead. Poland started 0 for 13 from 3-point range, not getting one from beyond the arc to fall until Michal Sokolowski connected with 1:28 left in the half — and by then, the U.S. lead was 18.There was little to play for except pride — and the Americans were playing with the realization that, for some of them, it easily could be their last time wearing the red, white and blue uniforms with “USA” across the chest. The roster for the U.S. trip to the Tokyo Olympics next summer is likely to look considerably different than this one.It had much meaning to Poland coach Mike Taylor as well. He’s an American, who lives in Florida, and mouthed along with the words to “The Star-Spangled Banner” when it played pregame.His team wasn’t eager to quit, either.Down 17 at the half, Poland made it a very serious game after intermission. Waczynski’s 3-pointer from the right corner late in the third got Poland within 54-47, and Lukasz Koszarek had a 3-point try that would have gotten his team within four with 8:21 remaining.TIP-INSU.S.: Kemba Walker (neck) didn’t play, joining Boston Celtics teammates Jayson Tatum (left ankle) and Marcus Smart (left hand) on the U.S. injured list. White started in Walker’s place at point guard. … Timing is everything — the 6-2 record for the U.S. here was better than silver-medalist Serbia (5-4) and bronze-medalist France (6-3) at the last World Cup. But losing in the quarterfinals doomed the U.S. medal hopes.Poland: The team had three players who played at the Division I level — Slaughter was a four-year player at Western Kentucky, guard Karol Gruszecki spent two years at Texas-Arlington and center Dominik Olejniczak started his career at Drake, then played two seasons at Ole Miss and will play this year at Florida State as a graduate transfer. … Poland started 4-0 in China, then dropped its last four games.GIVEAWAY ITEMSMitchell was the last U.S. player to leave the court in the pre-warmup period, ending about 45 minutes before game time. He took off his sneakers and tossed them to a couple of young fans in the crowd.UP NEXTU.S.: Has already qualified for 2020 Tokyo Olympics.Poland: Will participate in qualifying for 2020 Tokyo Olympics next year.
USAF / Kasey Zickmund WASHINGTON (AP) — The U.S. added a second COVID-19 vaccine to its arsenal last week, boosting efforts to beat back an outbreak so dire that the nation is regularly recording more than 3,000 deaths a day.Much-needed doses are set to arrive Monday after the Food and Drug Administration authorized an emergency rollout of the vaccine developed by Moderna Inc. and the National Institutes of Health.The move marks the world’s first authorization for Moderna’s shots. The vaccine is very similar to one from Pfizer Inc. and Germany’s BioNTech that’s now being dispensed to millions of health care workers and nursing home residents as the biggest vaccination drive in U.S. history starts to ramp up.The two work “better than we almost dared to hope,” NIH Director Dr. Francis Collins told The Associated Press. “Science is working here, science has done something amazing.” Early results of large, still unfinished studies show both vaccines appear safe and strongly protective although Moderna’s is easier to handle since it doesn’t need to be stored at ultra-frozen temperatures.A second vaccine represents a ray of hope amid despair as the virus continues to spread unabated even before holiday gatherings that are certain to further fuel the outbreak.The scourge has claimed more than 312,000 U.S. lives and killed 1.7 million people worldwide. New cases in the U.S. are running at over 216,000 per day on average. Deaths per day have hit all-time highs, eclipsing 3,600 on Wednesday.California has emerged as one of the most lethal hot spots, with hospitals running out of intensive care beds and ambulances lining up outside emergency rooms in scenes reminiscent of the calamity around New York City last spring. California on Friday reported over 41,000 new cases and 300 more deaths.When New York’s hospitals were in crisis, health care workers from across the country came to help out. This time, “there’s no cavalry coming” because so many hospitals are swamped, said Dr. Marc Futernick, an emergency room physician in Los Angeles.The nation is scrambling to expand vaccinations as rapidly as Moderna and Pfizer can churn out doses. Moderna’s is for people 18 and older, Pfizer’s starts at age 16.It’s just the beginning of “what we hope will be a big push to get this terrible virus behind us, although it will take many more months to get to all Americans,” Collins said.Moderna expects to have between 100 million and 125 million doses available globally in the first three months of 2021, with 85-100 million of those available in the U.S.Even with additional candidates in the pipeline, there won’t be enough for the general population until spring, and shots will be rationed in the meantime. And while health workers are enthusiastically embracing vaccination, authorities worry the public may need more reassurance to ensure more people get in line when it’s their turn.“Frankly if we don’t succeed in getting 80% or so of Americans immunized against COVID-19 by the middle of this 2021 year, we have the risk that this epidemic could go on and on and on,” Collins said.He is especially concerned that accurate information about the shots’ value reaches communities of color, which have been hard-hit by COVID-19 yet also are wary after years of health care disparities and research abuses.To try to help instill confidence, Vice President Mike Pence received the Pfizer-BioNTech shot on live TV Friday, along with Surgeon General Jerome Adams.FDA’s decision could help pave the way for other countries that are considering the Moderna vaccine, the first-ever regulatory clearance for the small Cambridge, Massachusetts, company. European regulators could authorize its use as soon as Jan. 6. Britain, Canada and a few other countries already have cleared the Pfizer-BioNTech shot, with a European Union decision due Monday.“What we want to always remember is one size does not fit all. We want to have options,” said Dr. Paul Duprex of the University of Pittsburgh.Moderna has about 5.9 million doses ready for shipment set to begin over the weekend, according to Operation Warp Speed, the government’s vaccine development program. Injections of health workers and nursing home residents continue next week, before other essential workers and vulnerable groups are allowed to get in line.Both Moderna’s and Pfizer-BioNTech’s shots are so-called mRNA vaccines, made with a groundbreaking new technology. They don’t contain any coronavirus – meaning they cannot cause infection. Instead, they use a piece of genetic code that trains the immune system to recognize the spike protein on the surface of the virus, ready to attack if the real thing comes along.Their development less than a year after the coronavirus first emerged set a speed record, but Collins stressed that shouldn’t worry people. The speed was due to billions in company and government investments paired with years of earlier scientific research, not any cut corners.“The rigor of the analysis of these vaccines is unprecedented,” Collins said. “We’re not done with this but hope is on the way, and the hope comes from this scientific brain trust that has pulled out all the stops.”Experts are hoping the two vaccines together will “break the back of the pandemic” when combined with masks and other precautions, said Dr. Arnold Monto of the University of Michigan, who chaired an advisory committee that publicly debated the shots’ evidence ahead of FDA’s decisions.The FDA’s main messages:Both the new Moderna vaccine and the Pfizer-BioNTech shot require two doses several weeks apart. The second dose must be from the same company as the first.In a study of 30,000 volunteers, the Moderna vaccine was more than 94% effective at preventing symptomatic COVID-19 in people 18 and older. It also strongly protected older adults, who are most vulnerable.The inoculated can’t throw away their masks as it’s not yet clear either vaccine prevents silent, symptomless virus spread. But there was a hint that Moderna’s shot might provide some protection against asymptomatic infection.The Moderna study uncovered no major safety problems. Like with the Pfizer-BioNTech shot, expect sore arms, fever, fatigue and muscle aches, which are signs the immune system is revving up.Both vaccines carry “a remote chance” of causing a severe allergic reaction. Moderna’s study turned up none of these, though a handful were reported in Britain as the Pfizer-BioNTech vaccinations got underway and the FDA is looking into five in the U.S., including a severe reaction in Alaska. The vaccines’ ingredients aren’t identical. Still, after any COVID-19 vaccination, people should stick around for 15 minutes – or 30 minutes if they have a history of severe allergies – so if they do have a reaction, it can be treated immediately.Both vaccines remain experimental, and the government is closely monitoring safety in case rare problems crop up.Additional studies are needed to tell if the vaccine should be used by pregnant women and children. Women who are pregnant or breastfeeding should discuss whether to get the vaccine with their doctor.Associated Press reporter Amy Taxin contributed to this report from Orange County, California. The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content. Share:Click to share on Facebook (Opens in new window)Click to share on Twitter (Opens in new window)Click to email this to a friend (Opens in new window)
The NZ Herald reportsAn Auckland man who beat his wife with a hammer because she complained they weren’t holding hands while watching a movie together was allowed to walk free from court. Judge Philippa Cunningham ruled the consequences of convictions for Yasir Mohib, who pleaded guilty to three violence charges, were out of proportion to the gravity of the offending and discharged him without conviction. She placed particular importance on the possibility the 31-year-old, who has three New Zealand-born childrenand two wives (!!)might be deported to Pakistan despite the legal principle that a sentencing judge should not usurp the role of Immigration authorities. But her decision was later overturned by the High Court and labelled “plainly wrong” – the third time Judge Cunningham has granted a discharge without conviction and been successfully appealed.Good decision – and Judge Cunningham should be put in charge of the small claims Dispute Tribunal to mitigate her dumb decisions.But here’s the interesting bit. Mr Mohib has two wives. Correct – a polygamous relationship which the State appears to be turning a blind eye to, simply because Mr Mohib has only registered one of the marriages.Yasir Mohib, 31, from Pakistani. Legally married to the victim, mother of their 3 children. Has a second “wife” whom he married in a religious ceremony… Judge Cunningham… noted obvious immigration consequences and the desperate need for Mohib to work again because of dire financial circumstances.Um…. nothing about an illegal polygamous relationship!Will Louisa Wall be introducing a marriage equality bill to protect this consenting love of three people?
PORT OF SPAIN, Trinidad – Millions of dollars are now owed to the National Entrepreneurship Development Company (NEDCO) by persons who borrowed funds to start their own businesses and never paid back, according to Minister of Labour and Small and Micro Enterprise Development, Errol Mc Leod. In some cases, he said, the funds were not used for what they were intended.Mc Leod said efforts are now being made to recover the monies. He made the disclosure yesterday, while speaking to reporters, following a public consultation on ‘Enterprise Development through Business Incubation’.Minister Mc Leod said there was “hardly any evidence” to support the recipients involvement in business development with the funds received. The loans disbursed would have ranged from TT$250,000 (US$39,370) to TT$500,000 (US$78,740) each. Mc Leod expressed dissatisfaction with the operations of NEDCO because of improprieties which he said came to his attention a year ago, when he took office. However, he said he could divulge any details because of an ongoing investigation.NEDCO was established in 2002 as the implementing agency for government’s policy on small and micro-enterprise development. Caribbean 360 News Share 30 Views no discussions Sharing is caring! Share Share Tweet NewsRegional Government owed millions for business loans by: – June 3, 2011